SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IPIC
IPIC 0.00010000.0%Dec 18 4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: WeirdPro Randy who wrote (747)9/29/1997 12:26:00 AM
From: far east   of 1359
 
During last quarter's conference call, IPIC is already training salespersons for the launch of Citicoline. It shoud hit the market during the first half of 1998.

Certainly, IPIC's pipeline is not in the compound stage per Barron's article. I will pick up additional shares sometimes this week before IPIC officially submits its NDA for Citicoline in October.

You get rich and wealthy in a media storm like this. You can pick up IPIC at a fraction of its value.

Legal problems will not go away for 2-3 years. I doubt that IPIC will be liable at all. By then, IPIC will have hundreds of millions in sales.

UCLA did a Redux study with more than a thousand patients with control group. It was a scientific study over the course of a year. There was no heart valve problem observed during the study. The valve problem just got blown away by the media and plantiff's lawyers. I hope that UCLA will publish the study soon.

A good buying opportunity tomorrow.

Best Wishes to all IPIC shareholders.

Barron's story is totally one-sided
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext